» Articles » PMID: 36278163

Coadministration of Compound Danshen Dripping Pills and Bezafibrate Has a Protective Effect Against Diabetic Retinopathy

Overview
Journal Front Pharmacol
Date 2022 Oct 24
PMID 36278163
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR) is increasingly becoming a main complication of diabetes, and is difficult to cure. In our research, network pharmacology analysis suggested that both compound Danshen dripping pills (CDDP) and bezafibrate (BZF) have potential protective effects against DR and the two drugs may act synergistically. The pharmacological effects of the coadministration of CDDP and BZF were elucidated in db/db mice, which simulate DR. Fluorescein fundus angiography showed that coadministration attenuated vascular leakage. Optical coherence tomography and hematoxylin and eosin staining showed that coadministration improved retinal thickness better than CDDP monotherapy. In addition, cell fluorescence images of reactive oxygen species revealed that coadministration of CDDP and BZF had more potent effects against oxidative stress than CDDP monotherapy. Metabolomics analysis showed that coadministration reduced the ratio of oxidized glutathione to reduced glutathione further than CDDP monotherapy. Coadministration of CDDP and BZF may provide additional protective effects by resisting vascular leakage, increasing retinal thickness, and inhibiting inflammation and oxidative stress in DR.

Citing Articles

Pharmacological efficacy study of the cardio-cerebral stasis transforming medicines on cerebral ischemia and myocardial infarction in rats.

Liu R, Chen Y, Zhang X, Cai Y, Xu S, Xu Q Heliyon. 2024; 10(20):e39162.

PMID: 39640627 PMC: 11620065. DOI: 10.1016/j.heliyon.2024.e39162.


Role and molecular mechanism of Salvia miltiorrhiza associated with chemical compounds in the treatment of diabetes mellitus and its complications: A review.

Li J, Liu J, Shi W, Guo J Medicine (Baltimore). 2024; 103(16):e37844.

PMID: 38640337 PMC: 11029945. DOI: 10.1097/MD.0000000000037844.


Compound Danshen dripping pills prevent early diabetic retinopathy: roles of vascular protection and neuroprotection.

Xu X, Wang M, Zhang S, Wang J, Li X, Ma X Front Pharmacol. 2024; 15:1294620.

PMID: 38318138 PMC: 10839082. DOI: 10.3389/fphar.2024.1294620.


The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials.

Liu Z, Chen Y, Jie C, Wang J, Deng Y, Hou X Front Endocrinol (Lausanne). 2023; 14:1144290.

PMID: 37077355 PMC: 10106679. DOI: 10.3389/fendo.2023.1144290.


, : Toward the modernization of traditional Chinese medicine.

Yague E, Sun H, Hu Y Front Neurosci. 2022; 16:1057817.

PMID: 36440293 PMC: 9685990. DOI: 10.3389/fnins.2022.1057817.

References
1.
Zhang Q, Xiao X, Zheng J, Li M, Yu M, Ping F . Compound Danshen Dripping Pill Inhibits Retina Cell Apoptosis in Diabetic Rats. Front Physiol. 2018; 9:1501. PMC: 6207599. DOI: 10.3389/fphys.2018.01501. View

2.
Hammes H . Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. Diabetologia. 2017; 61(1):29-38. DOI: 10.1007/s00125-017-4435-8. View

3.
Luo D, Qin Y, Yuan W, Deng H, Zhang Y, Jin M . Compound Danshen Dripping Pill for Treating Early Diabetic Retinopathy: A Randomized, Double-Dummy, Double-Blind Study. Evid Based Complement Alternat Med. 2015; 2015:539185. PMC: 4592726. DOI: 10.1155/2015/539185. View

4.
Li X, Ren J, Zhang W, Zhang Z, Yu J, Wu J . LTM-TCM: A comprehensive database for the linking of Traditional Chinese Medicine with modern medicine at molecular and phenotypic levels. Pharmacol Res. 2022; 178:106185. DOI: 10.1016/j.phrs.2022.106185. View

5.
Liu M, Pan Q, Chen Y, Yang X, Zhao B, Jia L . Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy. Sci Rep. 2015; 5:11219. PMC: 4462147. DOI: 10.1038/srep11219. View